Chronic fentanyl treatments induce the up-regulation of μ opioid receptor mRNA in rat pheochromocytoma cells

Brain Research

Volumn 859, Issue 2, 2000, Pages 217-223

  Yoshikawa, Mayumi ^a   Nakayama, Hitoshi ^a   Ueno, Satoshi ^a   Hirano, Makito ^a   Hatanaka, Hiroshi ^b   Furuya, Hitoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Mitogen activated protein kinase; Receptor internalization; RT PCR

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ADENYLATE CYCLASE; BETA ACTIN; BETA FUNALTREXAMINE; CYCLIC AMP; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FENTANYL; MESSENGER RNA; MORPHINE; MU OPIATE RECEPTOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NALOXONE; RAS PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION;

ANALGESICS, OPIOID; ANIMALS; CELLS, CULTURED; CYCLIC AMP; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; FENTANYL; INTRACELLULAR FLUID; ISOQUINOLINES; PC12 CELLS; RATS; RECEPTORS, OPIOID, MU; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONAMIDES; THIONUCLEOTIDES; UP-REGULATION;

EID: 0034708550     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)01961-2     Document Type: Article

References (34)

1. M.E. Abood, Q. Tao, Characterization of a delta opioid receptor in rat pheochromocytoma cells, J. Pharmacol. Exp. Ther. 274 (1995) 1566-1573.
2. J.R. Arden, V. Segredo, Z. Wang, J. Lameh, W. Sadée, Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells, J. Neurochem. 65 (1995) 1636-1645.
3. T. Avidor-Reiss, I. Nevo, R. Levy, T. Pfeuffer, Z. Vogel, Chronic opioid treatment induces adenylyl cyclase V superactivation, J. Biol. Chem. 271 (1996) 21309-21315.
4. K.J. Blumer, G.L. Johnson, Diversity in function and regulation of MAP kinase pathways, Trends Biochem. Sci. 19 (1994) 236-240.
5. G. Bot, A.D. Blake, S. Li, T. Reisine, Fentanyl and its analogs desensitize the cloned mu opioid receptor, J. Pharmacol. Exp. Ther. 285 (1998) 1207-1218.
6. B.M.T. Burgering, J.L. Bos, Regulation of Ras-mediated signaling: more than one way to skin a cat, Trends Biochem. Sci. 20 (1995) 18-22.
7. Y. Chen, A. Mestek, J. Liu, J.A. Hurley, L. Yu, Molecular cloning and functional expression of a μ-opioid receptor from rat brain, Mol. Pharmacol. 44 (1993) 8-12.
8. S.R. Childers, Opioid receptor-coupled second messenger systems, Life Sci. 48 (1991) 1991-2003.
9. P. Erhardt, J. Troppmair, U.R. Rapp, G.M. Cooper, Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells, Mol. Cell Biol. 15 (1995) 5524-5530.
10. S. Finkbeiner, S.F. Tavasoie, A. Moloratsky, K.M. Jacobs, K.M. Harris, M.E. Grrenberf, CREB: a major mediator of neuronal neurotrophin receptors, Neuron 19 (1997) 1031-1047.
11. M. Frödin, P. Peraldi, E. van Obberghen, Cyclic AMP activates the mitogen-activated protein kinase cascade in PC 12 cells, J. Biol. Chem. 269 (1994) 6207-6214.
12. K. Fukuda, S. Kato, H. Morikawa, T. Shoda, K. Mori, Functional coupling of the δ-, μ-, and κ-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells, J. Neurochem. 67 (1996) 1309-1316.
13. H.B. Gustein, E.A. Rubie, A. Mansour, H. Akil, J.R. Woodgett, Opioid effects on mitogen-activated protein kinase signaling cascades, Anesthesiology 87 (1997) 1118-1126.
14. C. Harrison, D. Smart, D.O. Lambert, Stimulatory effects of opioids, Br. J. Anaesth. 81 (1998) 20-28.
15. P. Honoré, J. Buritova, J.M. Besson, The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by β-funaltrexamine, a selective μ,-opioid receptor antagonist, Brain Res. 732 (1996) 242-246.
16. 2+ stimulation of CREB-dependent transcription and ERK nuclear translocation, Neuron 21 (1998) 869-883.
17. B. Jordan, L.A. Devi, Molecular mechanisms of opioid receptor signal transduction, Br. J. Anaesth. 81 (1998) 12-19.
18. D.E. Keith, S.R. Murray, P.A. Zaki, P.C. Chu, D.V. Lissin, L. Kang, C.J. Evans, M. von Zastrow, Morphine activates opioid receptors without causing their rapid internalization, J. Biol. Chem. 271 (1996) 19021-19024.
19. J. Kraus, G. Horn, A. Zimprich, T. Simon, P. Mayer, V. Höllt, Molecular cloning and functional analysis of the rat μ, opioid receptor gene promoter, Biochem. Biophys. Res. Commun. 215 (1995) 591-597.
20. Y. Liang, A. Mestek, L. Yu, L.G. Carr, Cloning and characterization of the promoter region of the mouse μ, opioid receptor gene, Brain Res. 679 (1995) 82-88.
21. D.A. McClain, C.C. Hug, Intravenous fentanyl kinetics, Clin. Pharmacol. Ther. 28 (1980) 106-114.
22. B.H. Min, L.B. Augustin, R.F. Felsheim, J.A. Fuchs, H.H. Loh, Genomic structure and analysis of promoter sequence of a mouse μ, opioid receptor gene, Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 9081-9085.
23. E.J. Nestler, Molecular mechanisms of drug addiction, J. Neurosci. 12 (1992) 2439-2450.
24. Y. Nishizuka, Studies and perspectives of protein kinase C, Science 233 (1986) 305-312.
25. U. Nudel, R. Zakut, M. Shani, S. Neuman, Z. Levy, D. Yaffe, The nucleotide sequence of the rat cytoplasmic β-actin gene, Nucleic Acids Res. 11 (1983) 1759-1771.
26. P.L. Prather, A.W. Tsai, P.Y. Law, Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells, J. Pharmacol. Exp. Ther. 270 (1994) 177-184.
27. V. Segredo, N.T. Burford, J. Lameh, W. Sadée, A constitutively internalizing and recycling mutant of the μ,-opioid receptor, J. Neurochem. 68 (1997) 2395-2404.
28. S.L. Shafer, J.R. Varvel, Pharmacokinetics, pharmacodynamics, and rational opioid selection, Anesthesiology 74 (1991) 53-63.
29. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, D.C. Klenk, Measurement of protein using bicinchoninic acid, Anal. Biochem. 150 (1985) 76-85.
30. J. Szeberényi, H. Cai, G.M. Cooper, Effect of a dominant inhibitory Ha-ras mutation on neuronal differentiation of PC12 cells, Mol. Cell Biol. 10 (1990) 5324-5332.
31. J. Szeberényi, P. Erhardt, H. Cai, G.M. Cooper, Role of Ras in signal transduction from the nerve growth factor receptor: relationship to protein kinase C, calcium and cyclic AMP, Oncogene 7 (1992) 2105-2113.
32. A.E. Takemori, D.L. Larson, P.S. Portoghese, The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone, Eur. J. Pharmacol. 70 (1981) 445-451.
33. M.R. Vossler, H. Yao, R.D. York, M. Pan, C.S. Rim, P.J.S. Stork, cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap 1-dependent pathway, Cell 89 (1997) 73-82.
34. M. Yoshikawa, S. Ueno, M. Hirano, H. Nakayama, H. Furuya, Effects of fentanyl on survival of serum-deprived rat pheochromocytoma cells, Pharm. Pharmacol. Commun. 5 (1999) 603-607.